2014 Press/Media Releases:

Rayaldee™ Phase 3 Trial Meets Primary Endpoints
August 11, 2014

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy
August 7, 2014

OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE
July 28, 2014

OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEE
May 6, 2014

OPKO Health Announces Key Executive Appointments for Renal Division
April 3, 2014

 
     
     
 
   

© 2014 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use